0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Sterile Injectables - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-6X7258
Home | Market Reports | Health| Pharmacy
Global Sterile Injectables Market Insights and Forecast to 2028
BUY CHAPTERS

Sterile Injectables - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-6X7258
Report
September 2024
Pages:161
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sterile Injectables - Market Size

The global market for Sterile Injectables was estimated to be worth US$ 90500 million in 2023 and is forecast to a readjusted size of US$ 174170 million by 2030 with a CAGR of 9.8% during the forecast period 2024-2030

Sterile Injectables - Market

Sterile Injectables - Market

The development and manufacturing of sterile injectables is highly complex and capital intensive.
The operative cost for injectable is high as almost all injectables in present pharma market are toxic and infectious in natural, consequently, requiring a higher level of quality and significant care needs to be taken in order to ensure safe manufacture, packaging, storage, and distribution.
Increasing use of biologics in healthcare industry, with the gaining prominence, the emergence of antibody-drug conjugates (ADCs) and monoclonal antibodies (MA) into the drug development and clinical pipeline, has spurred growth of the sterile injectable market worldwide.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sterile Injectables, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sterile Injectables by region & country, by Type, and by Application.
The Sterile Injectables market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sterile Injectables.
Market Segmentation

Scope of Sterile Injectables - Market Report

Report Metric Details
Report Name Sterile Injectables - Market
Forecasted market size in 2030 US$ 174170 million
CAGR 9.8%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aspen Pharmacare Holding, Ltd, AstraZeneca plc, AuroMedics Pharma LLC, Baxter International Inc, Biocon Ltd, Cipla Pharmaceuticals, Inc., CSC Pharmaceuticals, Inc, Dr. Reddy's Laboratories Ltd, Eli Lilly & Company, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc, Kay Pharma, Lupin Limited, Merck & Co., Inc, Mylan N.V, Novartis AG, Pfizer Inc, Reddys Laboratories Limited, Sandoz International GmbH, Sun Pharmaceutical Industries, Ltd., Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Sterile Injectables manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Sterile Injectables in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Sterile Injectables in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Sterile Injectables - Market size in 2030?

Ans: The Sterile Injectables - Market size in 2030 will be US$ 174170 million.

Who are the main players in the Sterile Injectables - Market report?

Ans: The main players in the Sterile Injectables - Market are Aspen Pharmacare Holding, Ltd, AstraZeneca plc, AuroMedics Pharma LLC, Baxter International Inc, Biocon Ltd, Cipla Pharmaceuticals, Inc., CSC Pharmaceuticals, Inc, Dr. Reddy's Laboratories Ltd, Eli Lilly & Company, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc, Kay Pharma, Lupin Limited, Merck & Co., Inc, Mylan N.V, Novartis AG, Pfizer Inc, Reddys Laboratories Limited, Sandoz International GmbH, Sun Pharmaceutical Industries, Ltd., Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Inc.

What are the Application segmentation covered in the Sterile Injectables - Market report?

Ans: The Applications covered in the Sterile Injectables - Market report are Cancer, Diabetes, Cardiovascular Diseases, Central Nervous Systems, Infectious Disorders, Musculoskeletal

What are the Type segmentation covered in the Sterile Injectables - Market report?

Ans: The Types covered in the Sterile Injectables - Market report are Large Molecules, Small Molecules

Recommended Reports

Sterile Injectables

Sterile Packaging

Injection Devices

1 Market Overview
1.1 Sterile Injectables Product Introduction
1.2 Global Sterile Injectables Market Size Forecast
1.2.1 Global Sterile Injectables Sales Value (2019-2030)
1.2.2 Global Sterile Injectables Sales Volume (2019-2030)
1.2.3 Global Sterile Injectables Sales Price (2019-2030)
1.3 Sterile Injectables Market Trends & Drivers
1.3.1 Sterile Injectables Industry Trends
1.3.2 Sterile Injectables Market Drivers & Opportunity
1.3.3 Sterile Injectables Market Challenges
1.3.4 Sterile Injectables Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sterile Injectables Players Revenue Ranking (2023)
2.2 Global Sterile Injectables Revenue by Company (2019-2024)
2.3 Global Sterile Injectables Players Sales Volume Ranking (2023)
2.4 Global Sterile Injectables Sales Volume by Company Players (2019-2024)
2.5 Global Sterile Injectables Average Price by Company (2019-2024)
2.6 Key Manufacturers Sterile Injectables Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Sterile Injectables Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Sterile Injectables
2.9 Sterile Injectables Market Competitive Analysis
2.9.1 Sterile Injectables Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Sterile Injectables Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Injectables as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Large Molecules
3.1.2 Small Molecules
3.2 Global Sterile Injectables Sales Value by Type
3.2.1 Global Sterile Injectables Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sterile Injectables Sales Value, by Type (2019-2030)
3.2.3 Global Sterile Injectables Sales Value, by Type (%) (2019-2030)
3.3 Global Sterile Injectables Sales Volume by Type
3.3.1 Global Sterile Injectables Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Sterile Injectables Sales Volume, by Type (2019-2030)
3.3.3 Global Sterile Injectables Sales Volume, by Type (%) (2019-2030)
3.4 Global Sterile Injectables Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cancer
4.1.2 Diabetes
4.1.3 Cardiovascular Diseases
4.1.4 Central Nervous Systems
4.1.5 Infectious Disorders
4.1.6 Musculoskeletal
4.2 Global Sterile Injectables Sales Value by Application
4.2.1 Global Sterile Injectables Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sterile Injectables Sales Value, by Application (2019-2030)
4.2.3 Global Sterile Injectables Sales Value, by Application (%) (2019-2030)
4.3 Global Sterile Injectables Sales Volume by Application
4.3.1 Global Sterile Injectables Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Sterile Injectables Sales Volume, by Application (2019-2030)
4.3.3 Global Sterile Injectables Sales Volume, by Application (%) (2019-2030)
4.4 Global Sterile Injectables Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Sterile Injectables Sales Value by Region
5.1.1 Global Sterile Injectables Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sterile Injectables Sales Value by Region (2019-2024)
5.1.3 Global Sterile Injectables Sales Value by Region (2025-2030)
5.1.4 Global Sterile Injectables Sales Value by Region (%), (2019-2030)
5.2 Global Sterile Injectables Sales Volume by Region
5.2.1 Global Sterile Injectables Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Sterile Injectables Sales Volume by Region (2019-2024)
5.2.3 Global Sterile Injectables Sales Volume by Region (2025-2030)
5.2.4 Global Sterile Injectables Sales Volume by Region (%), (2019-2030)
5.3 Global Sterile Injectables Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Sterile Injectables Sales Value, 2019-2030
5.4.2 North America Sterile Injectables Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Sterile Injectables Sales Value, 2019-2030
5.5.2 Europe Sterile Injectables Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Sterile Injectables Sales Value, 2019-2030
5.6.2 Asia Pacific Sterile Injectables Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Sterile Injectables Sales Value, 2019-2030
5.7.2 South America Sterile Injectables Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Sterile Injectables Sales Value, 2019-2030
5.8.2 Middle East & Africa Sterile Injectables Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sterile Injectables Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sterile Injectables Sales Value
6.2.1 Key Countries/Regions Sterile Injectables Sales Value, 2019-2030
6.2.2 Key Countries/Regions Sterile Injectables Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Sterile Injectables Sales Value, 2019-2030
6.3.2 United States Sterile Injectables Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sterile Injectables Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sterile Injectables Sales Value, 2019-2030
6.4.2 Europe Sterile Injectables Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sterile Injectables Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sterile Injectables Sales Value, 2019-2030
6.5.2 China Sterile Injectables Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sterile Injectables Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sterile Injectables Sales Value, 2019-2030
6.6.2 Japan Sterile Injectables Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sterile Injectables Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sterile Injectables Sales Value, 2019-2030
6.7.2 South Korea Sterile Injectables Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sterile Injectables Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sterile Injectables Sales Value, 2019-2030
6.8.2 Southeast Asia Sterile Injectables Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sterile Injectables Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sterile Injectables Sales Value, 2019-2030
6.9.2 India Sterile Injectables Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sterile Injectables Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Aspen Pharmacare Holding, Ltd
7.1.1 Aspen Pharmacare Holding, Ltd Company Information
7.1.2 Aspen Pharmacare Holding, Ltd Introduction and Business Overview
7.1.3 Aspen Pharmacare Holding, Ltd Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Aspen Pharmacare Holding, Ltd Sterile Injectables Product Offerings
7.1.5 Aspen Pharmacare Holding, Ltd Recent Development
7.2 AstraZeneca plc
7.2.1 AstraZeneca plc Company Information
7.2.2 AstraZeneca plc Introduction and Business Overview
7.2.3 AstraZeneca plc Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.2.4 AstraZeneca plc Sterile Injectables Product Offerings
7.2.5 AstraZeneca plc Recent Development
7.3 AuroMedics Pharma LLC
7.3.1 AuroMedics Pharma LLC Company Information
7.3.2 AuroMedics Pharma LLC Introduction and Business Overview
7.3.3 AuroMedics Pharma LLC Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.3.4 AuroMedics Pharma LLC Sterile Injectables Product Offerings
7.3.5 AuroMedics Pharma LLC Recent Development
7.4 Baxter International Inc
7.4.1 Baxter International Inc Company Information
7.4.2 Baxter International Inc Introduction and Business Overview
7.4.3 Baxter International Inc Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Baxter International Inc Sterile Injectables Product Offerings
7.4.5 Baxter International Inc Recent Development
7.5 Biocon Ltd
7.5.1 Biocon Ltd Company Information
7.5.2 Biocon Ltd Introduction and Business Overview
7.5.3 Biocon Ltd Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Biocon Ltd Sterile Injectables Product Offerings
7.5.5 Biocon Ltd Recent Development
7.6 Cipla Pharmaceuticals, Inc.
7.6.1 Cipla Pharmaceuticals, Inc. Company Information
7.6.2 Cipla Pharmaceuticals, Inc. Introduction and Business Overview
7.6.3 Cipla Pharmaceuticals, Inc. Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Cipla Pharmaceuticals, Inc. Sterile Injectables Product Offerings
7.6.5 Cipla Pharmaceuticals, Inc. Recent Development
7.7 CSC Pharmaceuticals, Inc
7.7.1 CSC Pharmaceuticals, Inc Company Information
7.7.2 CSC Pharmaceuticals, Inc Introduction and Business Overview
7.7.3 CSC Pharmaceuticals, Inc Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.7.4 CSC Pharmaceuticals, Inc Sterile Injectables Product Offerings
7.7.5 CSC Pharmaceuticals, Inc Recent Development
7.8 Dr. Reddy's Laboratories Ltd
7.8.1 Dr. Reddy's Laboratories Ltd Company Information
7.8.2 Dr. Reddy's Laboratories Ltd Introduction and Business Overview
7.8.3 Dr. Reddy's Laboratories Ltd Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Dr. Reddy's Laboratories Ltd Sterile Injectables Product Offerings
7.8.5 Dr. Reddy's Laboratories Ltd Recent Development
7.9 Eli Lilly & Company
7.9.1 Eli Lilly & Company Company Information
7.9.2 Eli Lilly & Company Introduction and Business Overview
7.9.3 Eli Lilly & Company Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Eli Lilly & Company Sterile Injectables Product Offerings
7.9.5 Eli Lilly & Company Recent Development
7.10 Fresenius Kabi AG
7.10.1 Fresenius Kabi AG Company Information
7.10.2 Fresenius Kabi AG Introduction and Business Overview
7.10.3 Fresenius Kabi AG Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Fresenius Kabi AG Sterile Injectables Product Offerings
7.10.5 Fresenius Kabi AG Recent Development
7.11 Hikma Pharmaceuticals PLC
7.11.1 Hikma Pharmaceuticals PLC Company Information
7.11.2 Hikma Pharmaceuticals PLC Introduction and Business Overview
7.11.3 Hikma Pharmaceuticals PLC Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Hikma Pharmaceuticals PLC Sterile Injectables Product Offerings
7.11.5 Hikma Pharmaceuticals PLC Recent Development
7.12 Johnson & Johnson Services, Inc
7.12.1 Johnson & Johnson Services, Inc Company Information
7.12.2 Johnson & Johnson Services, Inc Introduction and Business Overview
7.12.3 Johnson & Johnson Services, Inc Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Johnson & Johnson Services, Inc Sterile Injectables Product Offerings
7.12.5 Johnson & Johnson Services, Inc Recent Development
7.13 Kay Pharma
7.13.1 Kay Pharma Company Information
7.13.2 Kay Pharma Introduction and Business Overview
7.13.3 Kay Pharma Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Kay Pharma Sterile Injectables Product Offerings
7.13.5 Kay Pharma Recent Development
7.14 Lupin Limited
7.14.1 Lupin Limited Company Information
7.14.2 Lupin Limited Introduction and Business Overview
7.14.3 Lupin Limited Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Lupin Limited Sterile Injectables Product Offerings
7.14.5 Lupin Limited Recent Development
7.15 Merck & Co., Inc
7.15.1 Merck & Co., Inc Company Information
7.15.2 Merck & Co., Inc Introduction and Business Overview
7.15.3 Merck & Co., Inc Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Merck & Co., Inc Sterile Injectables Product Offerings
7.15.5 Merck & Co., Inc Recent Development
7.16 Mylan N.V
7.16.1 Mylan N.V Company Information
7.16.2 Mylan N.V Introduction and Business Overview
7.16.3 Mylan N.V Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Mylan N.V Sterile Injectables Product Offerings
7.16.5 Mylan N.V Recent Development
7.17 Novartis AG
7.17.1 Novartis AG Company Information
7.17.2 Novartis AG Introduction and Business Overview
7.17.3 Novartis AG Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Novartis AG Sterile Injectables Product Offerings
7.17.5 Novartis AG Recent Development
7.18 Pfizer Inc
7.18.1 Pfizer Inc Company Information
7.18.2 Pfizer Inc Introduction and Business Overview
7.18.3 Pfizer Inc Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Pfizer Inc Sterile Injectables Product Offerings
7.18.5 Pfizer Inc Recent Development
7.19 Reddys Laboratories Limited
7.19.1 Reddys Laboratories Limited Company Information
7.19.2 Reddys Laboratories Limited Introduction and Business Overview
7.19.3 Reddys Laboratories Limited Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Reddys Laboratories Limited Sterile Injectables Product Offerings
7.19.5 Reddys Laboratories Limited Recent Development
7.20 Sandoz International GmbH
7.20.1 Sandoz International GmbH Company Information
7.20.2 Sandoz International GmbH Introduction and Business Overview
7.20.3 Sandoz International GmbH Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Sandoz International GmbH Sterile Injectables Product Offerings
7.20.5 Sandoz International GmbH Recent Development
7.21 Sun Pharmaceutical Industries, Ltd.
7.21.1 Sun Pharmaceutical Industries, Ltd. Company Information
7.21.2 Sun Pharmaceutical Industries, Ltd. Introduction and Business Overview
7.21.3 Sun Pharmaceutical Industries, Ltd. Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Sun Pharmaceutical Industries, Ltd. Sterile Injectables Product Offerings
7.21.5 Sun Pharmaceutical Industries, Ltd. Recent Development
7.22 Teva Pharmaceutical Industries Ltd.
7.22.1 Teva Pharmaceutical Industries Ltd. Company Information
7.22.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
7.22.3 Teva Pharmaceutical Industries Ltd. Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Teva Pharmaceutical Industries Ltd. Sterile Injectables Product Offerings
7.22.5 Teva Pharmaceutical Industries Ltd. Recent Development
7.23 Valeant Pharmaceuticals, Inc.
7.23.1 Valeant Pharmaceuticals, Inc. Company Information
7.23.2 Valeant Pharmaceuticals, Inc. Introduction and Business Overview
7.23.3 Valeant Pharmaceuticals, Inc. Sterile Injectables Sales, Revenue and Gross Margin (2019-2024)
7.23.4 Valeant Pharmaceuticals, Inc. Sterile Injectables Product Offerings
7.23.5 Valeant Pharmaceuticals, Inc. Recent Development
8 Industry Chain Analysis
8.1 Sterile Injectables Industrial Chain
8.2 Sterile Injectables Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sterile Injectables Sales Model
8.5.2 Sales Channel
8.5.3 Sterile Injectables Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Sterile Injectables Market Trends
    Table 2. Sterile Injectables Market Drivers & Opportunity
    Table 3. Sterile Injectables Market Challenges
    Table 4. Sterile Injectables Market Restraints
    Table 5. Global Sterile Injectables Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Sterile Injectables Revenue Market Share by Company (2019-2024)
    Table 7. Global Sterile Injectables Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Sterile Injectables Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Sterile Injectables Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Sterile Injectables Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Sterile Injectables Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Sterile Injectables
    Table 13. Global Sterile Injectables Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Injectables as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Sterile Injectables Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Sterile Injectables Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Sterile Injectables Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Sterile Injectables Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Sterile Injectables Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Sterile Injectables Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Sterile Injectables Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Sterile Injectables Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Sterile Injectables Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Sterile Injectables Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Sterile Injectables Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Sterile Injectables Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Sterile Injectables Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Sterile Injectables Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Sterile Injectables Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Sterile Injectables Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Sterile Injectables Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Sterile Injectables Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Sterile Injectables Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Sterile Injectables Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Sterile Injectables Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Sterile Injectables Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Sterile Injectables Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Sterile Injectables Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Sterile Injectables Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Sterile Injectables Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Sterile Injectables Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Sterile Injectables Sales Value by Region (2019-2024) & (%)
    Table 44. Global Sterile Injectables Sales Value by Region (2025-2030) & (%)
    Table 45. Global Sterile Injectables Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Sterile Injectables Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Sterile Injectables Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Sterile Injectables Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Sterile Injectables Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Sterile Injectables Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Sterile Injectables Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Sterile Injectables Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Sterile Injectables Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Sterile Injectables Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Sterile Injectables Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Sterile Injectables Sales Volume, (2025-2030) & (K Units)
    Table 57. Aspen Pharmacare Holding, Ltd Company Information
    Table 58. Aspen Pharmacare Holding, Ltd Introduction and Business Overview
    Table 59. Aspen Pharmacare Holding, Ltd Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Aspen Pharmacare Holding, Ltd Sterile Injectables Product Offerings
    Table 61. Aspen Pharmacare Holding, Ltd Recent Development
    Table 62. AstraZeneca plc Company Information
    Table 63. AstraZeneca plc Introduction and Business Overview
    Table 64. AstraZeneca plc Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. AstraZeneca plc Sterile Injectables Product Offerings
    Table 66. AstraZeneca plc Recent Development
    Table 67. AuroMedics Pharma LLC Company Information
    Table 68. AuroMedics Pharma LLC Introduction and Business Overview
    Table 69. AuroMedics Pharma LLC Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. AuroMedics Pharma LLC Sterile Injectables Product Offerings
    Table 71. AuroMedics Pharma LLC Recent Development
    Table 72. Baxter International Inc Company Information
    Table 73. Baxter International Inc Introduction and Business Overview
    Table 74. Baxter International Inc Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Baxter International Inc Sterile Injectables Product Offerings
    Table 76. Baxter International Inc Recent Development
    Table 77. Biocon Ltd Company Information
    Table 78. Biocon Ltd Introduction and Business Overview
    Table 79. Biocon Ltd Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Biocon Ltd Sterile Injectables Product Offerings
    Table 81. Biocon Ltd Recent Development
    Table 82. Cipla Pharmaceuticals, Inc. Company Information
    Table 83. Cipla Pharmaceuticals, Inc. Introduction and Business Overview
    Table 84. Cipla Pharmaceuticals, Inc. Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Cipla Pharmaceuticals, Inc. Sterile Injectables Product Offerings
    Table 86. Cipla Pharmaceuticals, Inc. Recent Development
    Table 87. CSC Pharmaceuticals, Inc Company Information
    Table 88. CSC Pharmaceuticals, Inc Introduction and Business Overview
    Table 89. CSC Pharmaceuticals, Inc Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. CSC Pharmaceuticals, Inc Sterile Injectables Product Offerings
    Table 91. CSC Pharmaceuticals, Inc Recent Development
    Table 92. Dr. Reddy's Laboratories Ltd Company Information
    Table 93. Dr. Reddy's Laboratories Ltd Introduction and Business Overview
    Table 94. Dr. Reddy's Laboratories Ltd Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Dr. Reddy's Laboratories Ltd Sterile Injectables Product Offerings
    Table 96. Dr. Reddy's Laboratories Ltd Recent Development
    Table 97. Eli Lilly & Company Company Information
    Table 98. Eli Lilly & Company Introduction and Business Overview
    Table 99. Eli Lilly & Company Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Eli Lilly & Company Sterile Injectables Product Offerings
    Table 101. Eli Lilly & Company Recent Development
    Table 102. Fresenius Kabi AG Company Information
    Table 103. Fresenius Kabi AG Introduction and Business Overview
    Table 104. Fresenius Kabi AG Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Fresenius Kabi AG Sterile Injectables Product Offerings
    Table 106. Fresenius Kabi AG Recent Development
    Table 107. Hikma Pharmaceuticals PLC Company Information
    Table 108. Hikma Pharmaceuticals PLC Introduction and Business Overview
    Table 109. Hikma Pharmaceuticals PLC Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Hikma Pharmaceuticals PLC Sterile Injectables Product Offerings
    Table 111. Hikma Pharmaceuticals PLC Recent Development
    Table 112. Johnson & Johnson Services, Inc Company Information
    Table 113. Johnson & Johnson Services, Inc Introduction and Business Overview
    Table 114. Johnson & Johnson Services, Inc Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Johnson & Johnson Services, Inc Sterile Injectables Product Offerings
    Table 116. Johnson & Johnson Services, Inc Recent Development
    Table 117. Kay Pharma Company Information
    Table 118. Kay Pharma Introduction and Business Overview
    Table 119. Kay Pharma Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Kay Pharma Sterile Injectables Product Offerings
    Table 121. Kay Pharma Recent Development
    Table 122. Lupin Limited Company Information
    Table 123. Lupin Limited Introduction and Business Overview
    Table 124. Lupin Limited Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. Lupin Limited Sterile Injectables Product Offerings
    Table 126. Lupin Limited Recent Development
    Table 127. Merck & Co., Inc Company Information
    Table 128. Merck & Co., Inc Introduction and Business Overview
    Table 129. Merck & Co., Inc Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 130. Merck & Co., Inc Sterile Injectables Product Offerings
    Table 131. Merck & Co., Inc Recent Development
    Table 132. Mylan N.V Company Information
    Table 133. Mylan N.V Introduction and Business Overview
    Table 134. Mylan N.V Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 135. Mylan N.V Sterile Injectables Product Offerings
    Table 136. Mylan N.V Recent Development
    Table 137. Novartis AG Company Information
    Table 138. Novartis AG Introduction and Business Overview
    Table 139. Novartis AG Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 140. Novartis AG Sterile Injectables Product Offerings
    Table 141. Novartis AG Recent Development
    Table 142. Pfizer Inc Company Information
    Table 143. Pfizer Inc Introduction and Business Overview
    Table 144. Pfizer Inc Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 145. Pfizer Inc Sterile Injectables Product Offerings
    Table 146. Pfizer Inc Recent Development
    Table 147. Reddys Laboratories Limited Company Information
    Table 148. Reddys Laboratories Limited Introduction and Business Overview
    Table 149. Reddys Laboratories Limited Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 150. Reddys Laboratories Limited Sterile Injectables Product Offerings
    Table 151. Reddys Laboratories Limited Recent Development
    Table 152. Sandoz International GmbH Company Information
    Table 153. Sandoz International GmbH Introduction and Business Overview
    Table 154. Sandoz International GmbH Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 155. Sandoz International GmbH Sterile Injectables Product Offerings
    Table 156. Sandoz International GmbH Recent Development
    Table 157. Sun Pharmaceutical Industries, Ltd. Company Information
    Table 158. Sun Pharmaceutical Industries, Ltd. Introduction and Business Overview
    Table 159. Sun Pharmaceutical Industries, Ltd. Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 160. Sun Pharmaceutical Industries, Ltd. Sterile Injectables Product Offerings
    Table 161. Sun Pharmaceutical Industries, Ltd. Recent Development
    Table 162. Teva Pharmaceutical Industries Ltd. Company Information
    Table 163. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
    Table 164. Teva Pharmaceutical Industries Ltd. Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 165. Teva Pharmaceutical Industries Ltd. Sterile Injectables Product Offerings
    Table 166. Teva Pharmaceutical Industries Ltd. Recent Development
    Table 167. Valeant Pharmaceuticals, Inc. Company Information
    Table 168. Valeant Pharmaceuticals, Inc. Introduction and Business Overview
    Table 169. Valeant Pharmaceuticals, Inc. Sterile Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 170. Valeant Pharmaceuticals, Inc. Sterile Injectables Product Offerings
    Table 171. Valeant Pharmaceuticals, Inc. Recent Development
    Table 172. Key Raw Materials Lists
    Table 173. Raw Materials Key Suppliers Lists
    Table 174. Sterile Injectables Downstream Customers
    Table 175. Sterile Injectables Distributors List
    Table 176. Research Programs/Design for This Report
    Table 177. Key Data Information from Secondary Sources
    Table 178. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sterile Injectables Product Picture
    Figure 2. Global Sterile Injectables Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Sterile Injectables Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Sterile Injectables Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Sterile Injectables Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Sterile Injectables Report Years Considered
    Figure 7. Global Sterile Injectables Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Sterile Injectables Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Sterile Injectables Revenue in 2023
    Figure 10. Sterile Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Large Molecules Picture
    Figure 12. Small Molecules Picture
    Figure 13. Global Sterile Injectables Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Sterile Injectables Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Sterile Injectables Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Sterile Injectables Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Sterile Injectables Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Cancer
    Figure 19. Product Picture of Diabetes
    Figure 20. Product Picture of Cardiovascular Diseases
    Figure 21. Product Picture of Central Nervous Systems
    Figure 22. Product Picture of Infectious Disorders
    Figure 23. Product Picture of Musculoskeletal
    Figure 24. Global Sterile Injectables Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Sterile Injectables Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Sterile Injectables Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 27. Global Sterile Injectables Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Sterile Injectables Price by Application (2019-2030) & (USD/Unit)
    Figure 29. North America Sterile Injectables Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Sterile Injectables Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Sterile Injectables Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Sterile Injectables Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Sterile Injectables Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Sterile Injectables Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Sterile Injectables Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Sterile Injectables Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Sterile Injectables Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Sterile Injectables Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Sterile Injectables Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Sterile Injectables Sales Volume (%), (2019-2030)
    Figure 41. United States Sterile Injectables Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Sterile Injectables Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Sterile Injectables Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Sterile Injectables Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Sterile Injectables Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Sterile Injectables Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Sterile Injectables Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Sterile Injectables Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Sterile Injectables Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Sterile Injectables Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Sterile Injectables Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Sterile Injectables Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Sterile Injectables Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Sterile Injectables Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Sterile Injectables Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Sterile Injectables Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Sterile Injectables Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Sterile Injectables Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Sterile Injectables Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Sterile Injectables Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Sterile Injectables Sales Value by Application (%), 2023 VS 2030
    Figure 62. Sterile Injectables Industrial Chain
    Figure 63. Sterile Injectables Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS